The Enterprise Value as of June 2026 (TTM) for Cartesian Therapeutics, Inc. (RNAC) is 172.63M

According to Cartesian Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 172.63M. This represents a change of 76.56% compared to the average of 97.78M of the last 4 quarters.

Cartesian Therapeutics, Inc. (RNAC) Historical Enterprise Value (quarterly & annually)

How has RNAC Enterprise Value performed in the past?

The mean historical Enterprise Value of Cartesian Therapeutics, Inc. over the last ten years is 110.14M. The current 172.63M Enterprise Value has changed 15.57% with respect to the historical average. Over the past ten years (40 quarters), RNAC's Enterprise Value was at its highest in in the September 2021 quarter at 399.78M. The Enterprise Value was at its lowest in in the June 2016 quarter at -32003841.62.

Cartesian Therapeutics, Inc. (RNAC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cartesian Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cartesian Therapeutics, Inc. (RNAC) Average Enterprise Value

How has RNAC Enterprise Value performed in the past?

The current Enterprise Value of Cartesian Therapeutics, Inc. (RNAC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cartesian Therapeutics, Inc. (RNAC) Enterprise Value vs. Peers

How is RNAC’s Enterprise Value compared to its peers?

Cartesian Therapeutics, Inc.’s Enterprise Value is greater than Eupraxia Pharmaceuticals Inc. (160.53M), less than Inventiva S.A. (436.14M), less than Nautilus Biotechnology, Inc. (298.90M), less than Orchestra BioMed Holdings, Inc. (250.78M), greater than MediWound Ltd. (117.94M), greater than Aardvark Therapeutics, Inc. Common Stock (22.98M), less than Fennec Pharmaceuticals Inc. (217.04M), greater than Avalo Therapeutics, Inc. (144.04M), greater than Neonc Technologies Holdings, Inc. (95.18M), less than Genfit S.A. (513.33M),

Build a custom stock screener for Cartesian Therapeutics, Inc. (RNAC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cartesian Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cartesian Therapeutics, Inc. (RNAC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cartesian Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.